Sun Pharma Schedules Analyst/Institutional Investor Meetings from Sept 10-22
Sun Pharmaceutical Industries Limited will attend several analyst and institutional investor meetings from September 10 to September 22, 2026. The meetings include the UBS India Summit, Jefferies India Forum, Kotak Healthcare Forum, J.P. Morgan India Conference, and Anand Rathi G-200 Summit. No UPSI will be disclosed.
This is a routine disclosure of scheduled investor meetings. No new material information or Unpublished Price Sensitive Information (UPSI) is being shared, hence the impact is expected to be minimal.
The announcement is a routine intimation of upcoming investor meetings and does not contain any new financial results or strategic information that would positively or negatively impact the company's stock. It is a standard disclosure.
Sun Pharmaceutical Industries Limited has announced the schedule for upcoming analyst and institutional investor meetings. These meetings are set to take place between September 10, 2026, and September 22, 2026.
The schedule includes participation in the UBS India Summit 2026 in Mumbai on September 10, 2026, followed by the Jefferies India Forum 2026 in Delhi on September 16, 2026. The company will also attend the Kotak Institutional Equities Healthcare Forum 2026 in Mumbai on September 17, 2026, and the J.P. Morgan India Conference 2026 in Mumbai on September 21, 2026. The series of meetings will conclude with the Anand Rathi Annual Flagship Conference G-200 Summit 2026 in Mumbai on September 22, 2026.
All these meetings will be conducted physically and will include both group and one-on-one sessions. Sun Pharmaceutical Industries Limited has stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these interactions. The company also noted that the schedule is subject to change due to unforeseen circumstances.
A plain-language summary of a public exchange filing by Sun Pharmaceutical Industries Limited. Read the original for the full detail.